Charleston Providers Say Peptide Excitement Is Outpacing Science, But Approved GLP-1s Remain Well Studied
Providers in the Charleston area told WCSC that marketing for peptides is running ahead of the clinical evidence, particularly for compounds sold outside FDA-approved channels. They said the approved GLP-1 drugs carry long-term safety data that many other peptides do not.
0views
0comments